Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease

American Journal of Hypertension

Volumn 10, Issue 12 I, 1997, Pages 1391-1395

  Nakata, Yukiko ^a   Katsuya, Tomohiro ^a   Rakugi, Hiromi ^a   Takami, Seiju ^a   Sato, Noriyuki ^a   Kamide, Kei ^a   Ohishi, Mitsuru ^a   Miki, Tetsuro ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Apolipoprotein E; Cerebrovascular disease; Genetics; Polymorphism

Indexed keywords

ANGIOTENSINOGEN; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031408002     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00315-4     Document Type: Article

References (34)

1. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
2. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
3. Zhao Y, Higashimori K, Higaki J, et al. Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res. 17:1994;55-57.
4. Samuni NJ, Thompson JR, O'Toole L, et al. A meta-analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation. 94:1996;708-712.
5. Tiret L, Ricard S, Poirier O, et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction the ECTIM Study . J Hypertens. 13:1995;311-317.
6. Kamitani A, Rakugi H, Higaki J, et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 25:1995;950-953.
7. Katsuya T, Koike G, Yee TW, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 345:1995;1600-1603.
8. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 71:1993;160-165.
9. Luc G, Bard JM, Arveiler D, et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction The ECTIM Study . Arterioscler Thromb. 14:1994;1412-1419.
10. Tiret L, Knijff DP, Menzel HJ, et al. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations The EARS Study . European Atherosclerosis Research Study. Arterioscler Thromb. 14:1994;1617-1624.
11. Nakata Y, Katsuya T, Rakugi H, et al. Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia. Hypertension. 27:1996;1205-1209.
12. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
13. Iwai N, Ohmichi N, Nakamura Y, et al. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 90:1994;2622-2628.
14. Ohishi M, Rakugi H, Ogihara T. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 331:1994;1097-1098.
15. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension role of angiotensinogen . Cell. 71:1992;169-180.
16. Kamitani A, Rakugi H, Higaki J, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 8:1994;521-524.
17. Katzel LI, Fleg JL, Paidi M, et al. ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men. Arterioscler Thromb. 13:1993;1495-1500.
18. Costerousse O, Allegrini J, Lopez M, et al. Angiotensin I-converting enzyme in human circulating mononuclear cells genetic polymorphism of expression in T-lymphocytes . Biochem J. 290:1993;33-40.
19. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in human heart Effect of the deletion/insertion polymorphism . Circulation. 92:1995;1387-1388.
20. Barley J, Markus H, Brown M, et al. Lack of association between angiotensinogen polymorphism (M235T) and cerebrovascular disease and carotid atheroma. J Hum Hypertens. 9:1995;681-683.
21. Sharma P, Carter ND, Barley J, et al. Molecular approach to assessing the genetic risk of cerebral infarction deletion polymorphism in the gene encoding angiotensin 1-converting enzyme . J Hum Hypertens. 8:1994;645-648.
22. Markus HS, Barley J, Lunt R, et al. Angiotensin-converting enzyme gene deletion polymorphism A new risk factor for lacunar stroke but not carotid atheroma . Stroke. 26:1995;1329-1333.
23. Kario K, Kanai N, Saito K, et al. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation. 93:1996;1630-1633.
24. Catto A, Carter AM, Barrett JH, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke. 27:1996;435-440.
25. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group . Arterioscler Thromb. 11:1991;1237-1244.
26. Saunders AM, Roses AD. Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke. 24:1993;1416.
27. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular disease III. Stroke 1990;21:637-676.
28. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 51:1992;197-205.
29. Russ AP, Maerz W, Ruzicka V, et al. Rapid detection of the hypertension-associated Met235→ Thr allele of the human angiotensinogen gene. Hum Mol Genet. 2:1993;609-610.
30. Emi M, Wu LL, Robertson MA, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics. 3:1988;373-379.
31. Couderc R, Mahieux F, Bailleul S, et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease A case-control study . Stroke. 24:1993;661-664.
32. Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism . Stroke. 23:1992;1556-1562.
33. Pedro-Botet J, Senti M, Rubies-Prat J. Apolipoprotein E polymorphism and ischemic cerebrovascular disease (letter). Stroke. 25:1994;521.
34. Rubattus S, Volpe M, Kreutz R, et al. Chromosomal mapping of quantative trait loci contributing to stroke in a rat model of complex human disease. Nature Genet. 13:1996;429-434.